Dark Horse Consulting Group 與 Altruist Biologics 宣佈簽訂合作備忘錄，推動中國生物製劑的生產與開發

Dark Horse Consulting Group (DHCG), a biotherapeutic strategy and operations consulting firm, has signed a memorandum of understanding with Altruist Biologics, a wholly-owned subsidiary of Innovent Biologics and a global CDMO. The partnership combines DHCG's regulatory, manufacturing, and commercial expertise with Altruist's cGMP manufacturing infrastructure in China (232,000 liters total capacity across Suzhou and Hangzhou facilities) to provide sponsors a streamlined pathway for clinical and commercial-scale biologics production.